Artificial Intelligence (AI) aimed at detecting skin cancer is not yet ready for use in primary care settings, due to a lack of evidence in settings where the prevalence of skin cancer is low, according to CanTest researchers. The researchers emphasise that AI technology demonstrates promising results in detecting skin cancer in images from specialist […]
New research to improve diagnosis of prostate cancer
New research will discover how well the Prostate Specific Antigen (PSA) test works to catch harmful forms of prostate cancer in men visiting their GP. The CanTest team, from Cambridge and Exeter Universities, will then try out a new way to combine PSA results with other data to help improve the diagnosis of prostate cancer. Prostate cancer […]
Research on detecting cancer in primary care wins RCGP Research Paper of the Year award
Dr Garth Funston and colleagues have won the 2020 Research Paper of the Year for Clinical Research, awarded by the Royal College of General Practitioners, for their paper on detecting cancer in primary care. The research shows that CA125, a simple blood test available in primary care, is useful for ovarian cancer detection in symptomatic […]
How patients and the public are involved in research to improve the early diagnosis of cancer
Patient and public involvement in research: in this Primary Care Unit case study, we learn that the CanTest Collaborative has had PPI at its heart from the outset, aiming to improve the early diagnosis of cancer in primary care settings Summary: The CanTest Collaborative is a great example of how to include patients and members […]
Artificial intelligence techniques could help with earlier diagnosis of cancer in primary care: a systematic review
Artificial Intelligence (AI) techniques can be applied to primary care data to facilitate the early diagnosis of cancer, according to the first international review of studies on this topic. Promising studies applied AI techniques to some elements of the electronic health record (EHR), but did not incorporate all of the available data. Some commercially developed […]
Biomarkers for the early detection of upper-gastrointestinal cancers in primary care: a systematic review
A new systematic review guided by the CanTest Framework found that while there is a large number of biomarkers being developed for the detection of upper GI cancers, more evidence from evaluations in low-prevalence populations like primary care is still needed before their adoption in clinical practice can be recommended. Cancers of the stomach, oesophagus, […]